Figure 2 — Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial

Research Paper|Volume 13, Issue 3|pp. 3994–4006

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial

Back to articleFigure 2(2 of 3)

100%

Figure 2.Effect of Ticagrelor/aspirin therapy compared with Clopidogrel/aspirin therapy on high on-treatment platelet reactivity (HOPR) during study time course stratified by metabolizer status. (A) Carriers; (B) Non-carriers.